Ondansetron and Prednisone Dosing for 11.34 kg Patient
Ondansetron Dosing
For a patient weighing 11.34 kg, administer ondansetron 0.15 mg/kg IV (1.7 mg) or 4 mg orally, depending on the clinical indication and route preference. 1
Weight-Based Calculation
- IV dosing: 0.15 mg/kg × 11.34 kg = 1.7 mg IV
- Oral dosing: The pediatric data shows that 4 mg oral doses were used in children younger than 12 years with similar efficacy to 8 mg doses in older children 2
Clinical Context Considerations
The ASCO guidelines specify ondansetron 0.15 mg/kg IV for radiation-induced nausea/vomiting across all risk categories 1. For chemotherapy-induced nausea in pediatric patients, trials demonstrated that initial IV doses ranged from 0.04 to 0.87 mg/kg (total 2.16-12 mg), followed by oral doses of 4-24 mg daily 2.
Important caveat: Pediatric pharmacokinetic studies show that children younger than 6 months require dose reduction to 0.1 mg/kg due to immature clearance mechanisms 3. However, for children over 6 months (which likely applies to an 11.34 kg patient), the standard 0.15 mg/kg dose is appropriate.
Prednisone Dosing
For a patient weighing 11.34 kg requiring standard nephrotic syndrome dosing (60 mg/m²), use the weight-based approximation formula: [2 × W + 8] = 31 mg daily. 4
Dosing Calculations
For 60 mg/m² equivalent:
- Formula: [2 × 11.34 + 8] = 30.7 mg (round to 31 mg)
- This approximates BSA-based dosing with only 3.4% average error 4
For 40 mg/m² equivalent:
- Formula: [11.34 + 11] = 22.3 mg (round to 22 mg)
- This approximates BSA-based dosing with only 2.2% average error 4
Critical Dosing Pitfall
Do not use the simplified 2 mg/kg dosing for this weight range. The traditional 2 mg/kg calculation (22.7 mg) significantly underdoses children under 30 kg compared to BSA-based dosing of 60 mg/m² 5. Studies demonstrate that 2 mg/kg produces only 85% of the intended BSA-based dose in this weight range, with 30% of patients receiving more than 5 mg/day below the recommended dose 5.
Why This Matters
The weight-based formula [2 × W + 8] eliminates the need for height measurement and complex BSA calculations while maintaining dosing accuracy. This is particularly important because underdosing prednisone in conditions like nephrotic syndrome can lead to treatment failure and disease relapse.
Context-Specific Guidance
If using ondansetron for chemotherapy: Start with 0.15 mg/kg IV before chemotherapy, then transition to 4 mg oral three times daily for maintenance 2
If using ondansetron for radiation therapy: 0.15 mg/kg IV or 8 mg oral once daily before radiation, with the understanding that pediatric patients may use 4 mg doses 1
If using prednisone for nephrotic syndrome: Use 31 mg daily (approximating 60 mg/m²) for initial therapy, not the 2 mg/kg calculation which would underdose this patient 4, 5